Keywords: Parkinson's Disease, Parkinson's Disease
Motivation: Neuromelanin is a pigment that accumulates specifically in neurons population that are vulnerable in Parkinson's disease. The role of neuromelanin in pathogenesis is still unclear.
Goal(s): We tested the hypothesis that there is a pathogenic threshold of neuromelanin accumulation that triggers neurodegeneration in Parkinson's disease patients.
Approach: We performed longitudinal neuromelanin-MRI imaging of the substantia nigra of Parkinson's disease, prodromal Parkinson's disease (iRBD) patients, and healthy volunteers.
Results: We confirmed accelerated decrease of neuromelanin-MRI signal in patients with Parkinson's disease, which started from the maximum of healthy volunteer, in line with hypothetic pathogenic threshold. iRBD patients showed similar trajectory delayed by 5 years.
Impact: Results support the hypothesis of a pathogenic threshold of neuromelanin. Its role in Parkinson's disease pathogenesis needs more investigations. Late reach of this threshold in prodromal patients results in delayed age of Parkinson's disease onset, suggesting different progression pattern.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords